GUTS
FRACTYL HEALTH, INC.Company Information
- Company Name
- FRACTYL HEALTH, INC.
- CIK
- CIK0001572616
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- GUTS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- GUTS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-14
- Last sale
- 2025-01-31
- Shares purchased (TTM)
- 246,425
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 70,681,199
- Shares outstanding
- 158,648,963
- Ownership
- 44.55%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 3.26%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Preferred Stock | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 47 | 63 | 82 | 78 | 22 | 42 | 67 | 85 | 102 | 121 | ||||||
| Inventory Net | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 3 | 6 | 2 | 4 | 5 | 4 | 3 | 4 | 3 | ||||||
| Assets Current | 50 | 66 | 88 | 80 | 27 | 47 | 72 | 88 | 107 | 124 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash Noncurrent | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | ||||||
| Operating Lease Right Of Use Asset | 26 | 26 | 27 | 27 | 28 | 28 | 28 | 29 | 29 | 30 | ||||||
| Other Assets Noncurrent | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 3 | ||||||
| Assets | 82 | 99 | 121 | 114 | 62 | 83 | 108 | 127 | 146 | 164 | ||||||
Liabilities Current | ||||||||||||||||
| Accounts Payable Current | 1 | 2 | 2 | 1 | 4 | 1 | 3 | 2 | 2 | 1 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 10 | 9 | 12 | 12 | 13 | 12 | 12 | 9 | 7 | 9 | ||||||
| Operating Lease Liability Current | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | ||||||
| Liabilities Current | 16 | 15 | 18 | 19 | 22 | 19 | 20 | 16 | 14 | 13 | ||||||
| Long Term Notes Payable | 30 | 30 | 31 | 31 | 30 | 29 | 30 | 30 | 28 | 29 | ||||||
| Operating Lease Liability Noncurrent | 25 | 26 | 26 | 26 | 27 | 27 | 27 | 28 | 28 | 28 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Liabilities | 84 | 78 | 112 | 117 | 80 | 77 | 80 | 77 | 76 | 79 | ||||||
Stockholders Equity | ||||||||||||||||
| Preferred Stock Value | - | - | 0 | - | - | - | 0 | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 571 | 568 | 566 | 509 | 449 | 445 | 444 | 441 | 438 | 434 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -573 | -547 | -556 | -513 | -467 | -439 | -415 | -390 | -367 | -350 | ||||||
| Stockholders Equity | -2 | 21 | 9 | -3 | -18 | 6 | 28 | 50 | 71 | 84 | ||||||
| Liabilities And Stockholders Equity | 82 | 99 | 121 | 114 | 62 | 83 | 108 | 127 | 146 | 164 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Temporary Equity | ||||||||||||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 159 | 159 | 153 | 132 | 50 | 49 | 49 | 48 | 48 | 48 | ||||||
| Shares Outstanding | 159 | 159 | 153 | 132 | 50 | 49 | 49 | 48 | 48 | 48 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialFRACTYL HEALTH, INC. (GUTS) — SEC Financial Statements & Analysis
FRACTYL HEALTH, INC. (GUTS) is a surgical & medical instruments & apparatus company, incorporated in DE. FRACTYL HEALTH, INC. trades on Nasdaq as: GUTS. FRACTYL HEALTH, INC. (GUTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, FRACTYL HEALTH, INC. carries a market cap of $125.97M, a P/E ratio of -1.19x, a P/B ratio of -75.66x, a P/S ratio of 34266.07x, an enterprise value of $105.02M, and an EV/EBITDA multiple of -1.24x. On profitability, it posts a gross margin of 46.24%, an operating margin of -3291400.00%, a net margin of -4131133.33%, a Return on Equity (ROE) of 1063.04%, and a Return on Assets (ROA) of -146.75%. Per share, it reports EPS of $-0.67, diluted EPS of $-0.67, free cash flow per share of $-0.52, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 4.08% year-over-year, and EPS growth of -67.82% year-over-year. On the balance sheet, it maintains a current ratio of 3.15x, a quick ratio of 3.00x, working capital of $33.87M, a debt-to-equity ratio of -50.23x, a debt ratio of 1.02, free cash flow of $-82.98M (TTM), and net debt of $-20.95M. Figures sourced from SEC EDGAR.
- Market Cap
- $125.97M
- P/E TTM
- -1.19x
- EPS TTM
- $-0.67
- P/B TTM
- -75.66x
- ROE TTM
- 1063.04%
- ROA TTM
- -146.75%
- Debt To Equity
- -50.23x
- Free Cash Flow TTM
- $-82.98M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is FRACTYL HEALTH, INC. in?
FRACTYL HEALTH, INC. (GUTS) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does GUTS trade on?
FRACTYL HEALTH, INC. (GUTS) trades on the Nasdaq.
Where is FRACTYL HEALTH, INC. incorporated?
FRACTYL HEALTH, INC. is incorporated in DE.
When was FRACTYL HEALTH, INC. (GUTS)'s most recent SEC filing?
FRACTYL HEALTH, INC. (GUTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is GUTS's market cap?
FRACTYL HEALTH, INC. (GUTS) has a market capitalization of $125.97M as of 2026-06-30.
What is GUTS's EPS (earnings per share)?
FRACTYL HEALTH, INC. (GUTS)'s trailing twelve month EPS is $-0.67 as of 2026-06-30.
What is GUTS's ROE (return on equity)?
FRACTYL HEALTH, INC. (GUTS)'s trailing twelve month Return on Equity (ROE) is 1063.04% as of 2026-06-30.
What is GUTS's ROA (return on assets)?
FRACTYL HEALTH, INC. (GUTS)'s trailing twelve month Return on Assets (ROA) is -146.75% as of 2026-06-30.
What is GUTS's EV/EBITDA?
FRACTYL HEALTH, INC. (GUTS)'s trailing twelve month EV/EBITDA is -1.24x as of 2026-06-30.